We are live on
!
Find out more
MNG
Manning & Napier Group Portfolio holdings
AUM
$8.76B
1-Year Est. Return
23.27%
This Fund
S&P 500
This Quarter
Est. Return
+5.03%
1 Year Est. Return
+23.27%
3 Year Est. Return
+31.12%
5 Year Est. Return
+100.85%
10 Year Est. Return
–
AUM
$11.1B
AUM Growth
–
Cap. Flow
+$10.6B
Cap. Flow
% of AUM
95.54%
Top 10 Holdings %
Top 10 Hldgs %
28.26%
Holding
322
New
293
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Medtronic
MDT
|
+$395M |
| 2 |
Meta Platforms (Facebook)
META
|
+$374M |
| 3 |
ServiceNow
NOW
|
+$363M |
| 4 |
Novartis
NVS
|
+$330M |
| 5 |
Unilever
UL
|
+$319M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 25.11% |
| 2 | Technology | 14.4% |
| 3 | Consumer Discretionary | 11.94% |
| 4 | Industrials | 9.15% |
| 5 | Consumer Staples | 8.01% |
Similar funds
DPAM
CA
ICG
CW
WSTAM
CT
ZCM
CQS
Manning & Napier Group's Q4 2017 Portfolio in Review
Q4 2017 is the first quarter with a 13F filing on record for Manning & Napier Group, which disclosed 322 positions worth $11.1B. Its ten largest holdings account for 28% of the portfolio.
Its largest position is Medtronic: 4,934,563 shares worth $398M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, followed by Technology and Consumer Discretionary.
- Manning & Napier Group's largest Q4 2017 buy was Medtronic: 4,934,563 shares worth $398M.
- Manning & Napier Group's ten largest holdings make up 28% of its $11.1B portfolio in Q4 2017.
- Manning & Napier Group disclosed 322 positions in Q4 2017, its first 13F filing on record.
Based on Manning & Napier Group's 13F filing for Q4 2017, filed 5 Feb 2018.